EN DE

Livingstone Health Holdings Ltd (PRH) Fair Value & Analysis

Healthcare · SG · Market cap 16.4M SGD

LH Livingstone Health Holdings Ltd PRH · SG
Price0.0250 SGD
Fair Value0.0213 SGD
Upside-14.8%
Quality48/100
Watch Livingstone Health Holdings Ltd for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Thin margins · 0.8% net margin
Low debt · generates free cash flow
Trails peers (3/13)
Narrow moat 7/100
Evidence: Medium Range 0.0213 SGD – 0.0213 SGD Share as image

Fair value as of: Aug 13, 2026

From 21 valuation models · updated 5 days ago

Share price −3.8% over the past month.

Below-average quality, and screening another 15% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (0.0213 SGD). The favourable scenario is already priced in.
  • Solid but not exceptional quality (48/100) and above fair value, neither a clear bargain nor a standout compounder.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

0.1920 SGD 0.0150 SGD Fair Value 0.0213 SGD May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range 0.0150 SGD – 0.1920 SGD · the 0.0250 SGD price screens above the 0.0213 SGD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Livingstone Health Holdings Ltd (PRH) currently trades at 0.0250 SGD, while our model-based Fair Value estimate is 0.0213 SGD, implying the stock looks roughly 14.8% overvalued today. The Quality Score stands at 48/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Over the trailing twelve months, Livingstone Health Holdings Ltd generated revenue of 29.3M SGD at a net margin of 0.8%. Revenue grew 1.9% year over year. It earns a return on equity of -10.5%. Fundamentals as of Aug 13, 2026

The share trades about 32% below its 52-week high and 25% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -31% fair-value upside, at -15%, PRH screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF 0.0400 SGD 0.0400 SGD 0.0500 SGD 80
Residual Income 0.0100 SGD 0.0100 SGD 0.0100 SGD 76
Rev-Margin DCF 0.0400 SGD 0.0500 SGD 0.0700 SGD 74
All 21 models by family
DCF Models
FCF DCF 0.0300 SGD 0.0400 SGD 0.0500 SGD 38
Owner Earnings 0.0300 SGD 0.0400 SGD 0.0500 SGD 31
5Y Revenue Exit 0.0400 SGD 0.0500 SGD 0.0700 SGD 39
5Y EBITDA Exit 0.0300 SGD 0.0500 SGD 0.0600 SGD 41
5Y P/E Exit 0.0200 SGD 0.0200 SGD 0.0300 SGD 38
10Y Revenue Exit 0.0300 SGD 0.0500 SGD 0.0600 SGD 36
10Y EBITDA Exit 0.0300 SGD 0.0400 SGD 0.0600 SGD 37
10Y P/E Exit 0.0300 SGD 0.0300 SGD 0.0300 SGD 35
Earnings-Based
Graham-Dodd 0.0100 SGD 54
Dividend Discount
Gordon GGM 0.0100 SGD 0.0100 SGD 0.0100 SGD 70
DDM Multi-Stage 0.0100 SGD 0.0100 SGD 0.0100 SGD 61
Multiples
P/E Multiple 0.0100 SGD 0.0100 SGD 0.0100 SGD 63
P/S Multiple 0.0100 SGD 0.0100 SGD 58
P/B Multiple 0.0100 SGD 0.0100 SGD 55
EV/EBITDA 0.0400 SGD 0.0500 SGD 0.0600 SGD 54
EV/Revenue 0.0400 SGD 0.0600 SGD 0.0800 SGD 43
Asset-Based
NCAV (Graham) 0.0100 SGD 0.0100 SGD 0.0100 SGD 50
Growth DCF
Growth DCF 0.0400 SGD 0.0400 SGD 0.0500 SGD 80
Rev-Margin DCF 0.0400 SGD 0.0500 SGD 0.0700 SGD 74
Economic Profit
Residual Income 0.0100 SGD 0.0100 SGD 0.0100 SGD 76
Growth Earnings
Growth-Adj P/E 0.0100 SGD 0.0100 SGD 68

Widest divergence: DCF Models (0.0400 SGD) versus Dividend Discount (0.0100 SGD). Highest evidence: Growth DCF (80).

Notify me when PRH reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 29.3M SGD
Revenue growth (YoY) +1.9%
Net margin 0.8%
Return on equity -10.5%
Free cash flow 2.8M SGD FY2025
Operating margin -3.1%
More key figures
EPS growth (YoY) +58.7%
Net debt 539K SGD FY2025

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 48/100

Of which business quality 53 · Market factors (momentum, volatility) 42

Profitability 53
Margins and returns on capital today
Quality Growth 41
Are margins and returns improving?
Cashflow 71
Earnings quality: real cash, not paper profit
Fin. Strength 42
Balance sheet, leverage, solvency risk
Investment 84
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 37
Price trend over the last 3–12 months (market factor)
52W Momentum 42
Distance to the 52-week high (market factor)
Net Issuance 28
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Livingstone Health Holdings Limited, an investment holding company, provides medical treatment and consultancy services in Singapore. It operates through three segments: Specialist Healthcare, Primary Healthcare, and Others.

Full company description

Livingstone Health Holdings Limited, an investment holding company, provides medical treatment and consultancy services in Singapore. It operates through three segments: Specialist Healthcare, Primary Healthcare, and Others. The Specialist Healthcare segment offers medical services in anaesthesiology and pain management; orthopaedic surgery; dermatology; and internal medicine fields, as well as endocrinology services. The Primary Healthcare segment is involved in the provision of vaccination and general medicine services; and the management of general acute conditions, such as respiratory/gastrointestinal infections, musculoskeletal complaints, headaches, and dermatological conditions, as well as chronic conditions comprising diabetes, hypertension, dyslipidaemia, and asthma. The Other segment provides aesthetics and wellness, podiatry, nerve testing, and consultancy function solutions. This segment also engages in the management of healthcare solutions and provision of management services. It offers its services through a network of primary care clinics, private medical specialists, and allied health care professionals. The company was founded in 2015 and is headquartered in Singapore.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Livingstone Health Holdings Ltd reported revenue of 29.3M SGD in FY2025 versus 34.1M SGD in FY2021, a compound −3.8%/yr. Reported net income was 223K SGD in FY2025, compounding −47.9%/yr from FY2021.

Growth Quality 82/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
29.3M SGD
Latest YoY
+5.9%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−3.8%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+10.6%
Avg. growth/yr (8Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−11.8%
Revenue −3.8%/yr
FY21 34.1M SGD
FY22 32.9M SGD
FY23 25.4M SGD
FY24 27.6M SGD
FY25 29.3M SGD
Net income −47.9%/yr
FY21 3.0M SGD
FY22 723K SGD
FY23 −2.9M SGD
FY24 557K SGD
FY25 223K SGD

PRH screens 15% overvalued. Compare with HCA Healthcare, Inc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Livingstone Health Holdings Ltd Fair Value". https://www.fairvalue-calculator.com/stock/PRH

Peer Group

Medical Care Facilities · 268 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 48 · Below median
Fair Value upside −20% · Below median
Return on assets -0% · Bottom 25%
Net margin (TTM) 1% · Below median
Operating margin (TTM) -3% · Bottom 25%
Revenue growth 2% · Below median
Dividend yield (TTM) 3.2% · Above median
Debt / equity 0.22× · Higher than median

Valuation Multiples vs Medical Care Facilities median · lower = cheaper

P/B 1.86× · Pricier than median
P/S (TTM) 0.44× · Cheaper than 75% of peers
P/FCF 4.6× · Pricier than median
EV/EBITDA 5.2× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 7 · sector 27
FUTURE 10 · sector 23
PAST 0 · sector 29
HEALTH 89 · sector 90
DIVIDEND 64 · sector 41

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Compare Livingstone Health Holdings Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Livingstone Health Holdings Ltd (PRH) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of 0.0213 SGD versus a price of 0.0250 SGD, about −15% (overvalued).
What is the fair value of PRH?
Our model-based fair value for Livingstone Health Holdings Ltd is 0.0213 SGD (as of Aug 13, 2026), built from audited fundamentals. The current price is 0.0250 SGD.
What is the quality score of PRH?
Livingstone Health Holdings Ltd has a Quality Score of 48/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Livingstone Health Holdings Ltd (PRH)?
Livingstone Health Holdings Ltd reported trailing-twelve-month revenue of about 29.3M SGD (latest available figure, as of Aug 13, 2026).
What is the net profit margin of PRH?
The net profit margin of Livingstone Health Holdings Ltd is about 0.8%, meaning it keeps roughly 0.8% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Livingstone Health Holdings Ltd and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.